Skip to content
Screener

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$305M-15.5%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$19.7M+41.7%
AbbVie logo
AbbVieABBV
$265M+12.8%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$121K-64.2%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$20M+300%
LBR
LB Pharmaceuticals IncLBRX
$32K+52.4%

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Other long-term liabilities7,01048
Cash flows (used in) provided by operating activities(20,560)249,013
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions of property, plant and equipment(12,236)(23,126)
Proceeds from the sale of property, plant and equipment934
Proceeds from the sale of the Athlone facility1,708
Business combination, net of cash acquired(2,085,073)
Purchases of investments(44,804)(193,806)

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's capex?
Alkermes (ALKS) reported capex of $8.15M in Q2 2026.
How has Alkermes's capex changed year-over-year?
Alkermes's capex decreased by 37.4% year-over-year, from $13.02M to $8.15M.
What is the long-term trend for Alkermes's capex?
Over 4 years (2021 to 2025), Alkermes's capex has grown at a 9.6% compound annual growth rate (CAGR), from $28.02M to $40.44M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ask your AI about Alkermes's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude